Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2010, Article ID 819060, 8 pages
http://dx.doi.org/10.1155/2010/819060
Research Article

Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains

1Laboratoire de Parasitologie-Mycologie, Hôpital de la Timone, 264 Rue Saint Pierre, 13385 Marseille cedex 5, France
2UMR 956, UPVM, Hôpital Henri Mondor, 94010 Créteil, France
3Laboratoire de Parasitologie-Mycologie 163, Rue Auguste Broussonet, 34090 Montpellier, France
4Institut Pasteur de Tunis, Place Pasteur B.P. 74 Tunis Belvédère, Tunisie 1002, Tunisia

Received 18 January 2010; Revised 4 June 2010; Accepted 13 June 2010

Academic Editor: Isabel Sá-Correia

Copyright © 2010 C. Mary et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization. Programmes and projects, “Leishmaniasis: the disease and its epidemiology,” October 2009, http://www.who.int/leishmaniasis/disease_epidemiology/en/index.html.
  2. J. Alvar, S. Croft, and P. Olliaro, “Chemotherapy in the treatment and control of leishmaniasis,” Advances in Parasitology, vol. 61, pp. 223–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Bryceson, “A policy for leishmaniasis with respect to the prevention and control of drug resistance,” Tropical Medicine and International Health, vol. 6, no. 11, pp. 928–934, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Gramiccia, L. Gradoni, and S. Orsini, “Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment,” Annals of Tropical Medicine and Parasitology, vol. 86, no. 6, pp. 613–620, 1992. View at Google Scholar · View at Scopus
  5. S. Sundar, “Drug resistance in Indian visceral leishmaniasis,” Tropical Medicine and International Health, vol. 6, no. 11, pp. 849–854, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Ouellette and B. Papadopoulou, “Mechanisms of drug resistance in Leishmania,” Parasitology Today, vol. 9, no. 5, pp. 150–153, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Pérez-Victoria, A. Parodi-Talice, A. Torres, F. Gamarro, and S. Castanys, “ABC transporters in the protozoan parasite Leishmania,” International Microbiology, vol. 4, no. 3, pp. 159–166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Haimeur, C. Brochu, P.-A. Genest, B. Papadopoulou, and M. Ouellette, “Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae,” Molecular and Biochemical Parasitology, vol. 108, no. 1, pp. 131–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. Henderson, C. D. Sifri, M. Rodgers, D. F. Wirth, N. Hendrickson, and B. Ullman, “Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene,” Molecular and Cellular Biology, vol. 12, no. 6, pp. 2855–2865, 1992. View at Google Scholar · View at Scopus
  10. C. Guimond, N. Trudel, C. Brochu et al., “Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays,” Nucleic Acids Research, vol. 31, no. 20, pp. 5886–5896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Grondin, C. Kündig, G. Roy, and M. Ouellette, “Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae,” Nucleic Acids Research, vol. 26, no. 14, pp. 3372–3378, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. N. L. Uzcategui, Y. Zhou, K. Figarella, J. Ye, R. Mukhopadhyay, and H. Bhattacharjee, “Alteration in glycerol and metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin LmAQP1,” Molecular Microbiology, vol. 70, no. 6, pp. 1477–1486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. W. Ogunkolade, I. Vouldoukis, D. Frommel, B. Davoust, A. Rhodes-Feuillette, and L. Monjour, “Immunization of dogs with a Leishmania infantum-derived vaccine,” Veterinary Parasitology, vol. 28, no. 1-2, pp. 33–41, 1988. View at Google Scholar · View at Scopus
  14. D. G. Croan, D. A. Morrison, and J. T. Ellis, “Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences,” Molecular and Biochemical Parasitology, vol. 89, no. 2, pp. 149–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Dolai, R. K. Yadav, S. Pal, and S. Adak, “Leishmania major ascorbate peroxidase overexpression protects cells against reactive oxygen species-mediated cardiolipin oxidation,” Free Radical Biology and Medicine, vol. 45, no. 11, pp. 1520–1529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Bretagne, R. Durand, M. Olivi et al., “Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 4, pp. 828–831, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCt method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Beverley, “Gene amplification in Leishmania,” Annual Review of Microbiology, vol. 45, pp. 417–444, 1991. View at Google Scholar · View at Scopus
  19. J.-M. Ubeda, D. Légaré, F. Raymond et al., “Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy,” Genome Biology, vol. 9, no. 7, article R115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Ashutosh, S. Sundar, and N. Goyal, “Molecular mechanisms of antimony resistance in Leishmania,” Journal of Medical Microbiology, vol. 56, no. 2, pp. 143–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Dube, N. Singh, S. Sundar, and N. Singh, “Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models,” Parasitology Research, vol. 96, no. 4, pp. 216–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Sereno, E. Guilvard, S. Maquaire et al., “Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas,” Acta Tropica, vol. 80, no. 3, pp. 195–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. F. J. Gueiros-Filho, J. P. Viola, F. C. Gomes et al., “Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene,” Experimental Parasitology, vol. 81, no. 4, pp. 480–490, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Prasad, J. Kaur, and C. S. Dey, “Arsenite-resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment,” Parasitology Research, vol. 86, no. 8, pp. 661–664, 2000. View at Google Scholar · View at Scopus
  25. I. D. Ferreira, V. E. Do Rosário, and P. V. L. Cravo, “Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum,” Malaria Journal, vol. 5, article 1, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. F. Cowman, D. Galatis, and J. K. Thompson, “Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 3, pp. 1143–1147, 1994. View at Google Scholar · View at Scopus
  27. K. Katakura, M. Iwanami, H. Ohtomo, H. Fujise, and Y. Hashiguchi, “Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis,” Biochemical and Biophysical Research Communications, vol. 255, no. 2, pp. 289–294, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Légaré, D. Richard, R. Mukhopadhyay et al., “The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase,” Journal of Biological Chemistry, vol. 276, no. 28, pp. 26301–26307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Légaré, B. Papadopoulou, G. Roy et al., “Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania,” Experimental Parasitology, vol. 87, no. 3, pp. 275–282, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. K. C. Carter, S. Hutchison, F. L. Henriquez et al., “Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite γ-glutamylcysteine synthetase,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 1, pp. 88–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Grondin, A. Haimeur, R. Mukhopadhyay, B. P. Rosen, and M. Ouellette, “Co-amplification of the γ-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae,” EMBO Journal, vol. 16, no. 11, pp. 3057–3065, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Kündig, E. Leblanc, B. Papadopoulou, and M. Ouellette, “Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae,” Nucleic Acids Research, vol. 27, no. 18, pp. 3653–3659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Pedersen, K. Pedersen, H. Jensen, K. Finster, V. F. Jensen, and O. E. Heuer, “Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 4, pp. 775–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Thaithong, L. C. Ranford-Cartwright, N. Siripoon et al., “Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine,” Experimental Parasitology, vol. 98, no. 2, pp. 59–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Roper, R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson, “Intercontinental spread of pyrimethamine-resistant malaria,” Science, vol. 305, no. 5687, p. 1124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Nare, L. W. Hardy, and S. M. Beverley, “The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major,” Journal of Biological Chemistry, vol. 272, no. 21, pp. 13883–13891, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Quellette, F. Fase-Fowler, and P. Borst, “The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene,” EMBO Journal, vol. 9, no. 4, pp. 1027–1033, 1990. View at Google Scholar · View at Scopus
  38. H. L. Callahan and S. M. Beverley, “Heavy metal resistance: a new role for P-glycoproteins in Leishmania,” Journal of Biological Chemistry, vol. 266, no. 28, pp. 18427–18430, 1991. View at Google Scholar · View at Scopus
  39. S. M. Sunkin, P. McDonagh, M. L. Cunningham, S. M. Beverley, K. Stuart, and P. J. Myler, “Conservation of the LD1 region in Leishmania includes DNA implicated in LD1 amplification,” Molecular and Biochemical Parasitology, vol. 113, no. 2, pp. 315–321, 2001. View at Publisher · View at Google Scholar · View at Scopus